Biotech

All Articles

Lilly- supported weight loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' cannabis use medicine fails stage 2b, steering Indivior to rethink $100M possibility

.Aelis Farma's chances of protecting a fast, favorable selection on a $one hundred million choice re...

ProKidney standstills period 3 test not needed for tissue treatment confirmation

.ProKidney has actually stopped among a set of period 3 trials for its tissue therapy for renal heal...

Vaxcyte surges on 'remarkable' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what analysts referred to as "spectacular" phase 1/2 data for its own 31-valent ...

Recursion's mind ailment test presents little proof of effectiveness

.Recursion has discovered through an early test of its own tech-enabled strategy to medicine discove...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Call it an instance of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning science,...

Praxis epilepsy drug minimizes confiscations in phase 2 hearing

.Praxis Preciseness Medicines has racked up yet another midphase gain in epilepsy this year, along w...

Three directors surrender as Dyne articles combined information for DMD prospect

.After getting away a professional hold several years back, Dyne Therapeutics has actually revealed ...

Arrowhead fires off phase 3 information in rare metabolic ailment ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own give in front of a possible face-off along with Ionis, ...

Pfizer, Valneva show lyme illness chance efficient for second booster

.Pfizer and also Valneva might possess about two even more years to hang around prior to they create...